ETH 416
Generic Name: pancrelipase
Pill imprint ETH 416 has been identified as Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U.
Plaretase is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy.
Plaretase Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U is not subject to the Controlled Substances Act.
See also related documents.
Plaretase Images
- Generic Name:
- pancrelipase
- Imprint:
-
ETH
416 - Strength:
- Lipase 8,000 U / Amylase 30,000 U / Protease 30,000 U
- Color:
- Tan
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Ethex Corporation
- National Drug Code (NDC):
- 58177-0416
Advertisement
Search Again
